Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study

PURPOSE: To evaluate the efficacy and safety of imidafenacin (IM), a novel short half-life anticholinergic, as add-on therapy for male LUTS with nocturia and nocturnal polyuria. MATERIALS AND METHODS: This multicenter, prospective, randomized, open-labelled study was conducted and involved men who h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Osamu, Tsujimura, Akira, Akino, Hironobu, Segawa, Naoki, Tamada, Satoshi, Oguchi, Naoki, Kitagawa, Yasuhide, Tsuji, Hidenori, Watanabe, Akihiko, Inamoto, Teruo, Shimizu, Nobutaka, Fujiuchi, Yasuyoshi, Katsuoka, Yoji, Azuma, Haruhito, Matsuda, Tadashi, Namiki, Mikio, Uemura, Hirotsugu, Okuyama, Akihiko, Nonomura, Norio, Fuse, Hideki, Nakatani, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555202/
https://www.ncbi.nlm.nih.gov/pubmed/25224929
http://dx.doi.org/10.1007/s00345-014-1399-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555202/
https://www.ncbi.nlm.nih.gov/pubmed/25224929
http://dx.doi.org/10.1007/s00345-014-1399-x

Ejemplares similares